Orlando-based LensAR has raised $2 million of a targeted $7 million offering, according to a regulatory filing. The company is developing and commercializing laser and 3D imaging technology for refractive cataract surgery. The company raised $7 million in equity in…
Category: News
Promedior Announces Presentation Of Data At ARVO Demonstrating That PRM-151 (rhPTX-2) Suppresses Choroidal And Retinal Neovascularization
Promedior, Inc. today announced that data from preclinical studies of PRM-151 (recombinant human Pentraxin-2 (PTX-2)) will be presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)…
Singapore Eye Research Institute Performs Breakthrough Research On Chronic Inflammatory Eye Conditions With AB SCIEX TripleTOF™ 5600 System
AB SCIEX, a global leader in life science analytical technologies, today announced that the Singapore Eye Research Institute (SERI), an internationally known eye research center, will advance biomarker candidates it identified for chronic inflammatory …
Ophthalmologists Report Significant Changes In Prescribing Among Primary Open Angle Glaucoma Patients As Pfizer’s Xalatan Goes Generic
The impact of the genericization of Pfizer’s Xalatan at the end of March 2011 is reflected in changes to both current and anticipated ophthalmologist prescribing behavior for primary open angle glaucoma (POAG) patients…
Prospects Grow For Blindness Recovery, Australia
Prospects for recovery of lost vision have brightened with the release of new scientific findings showing that the use of gentle near infra-red light can reverse damage caused by exposure to bright light, up to a month after treatment…
Screening Begins For Active Ingredients For The Treatment Of Batten Disease
It is a rare disease with devastating consequences: Around first grade, the children start experiencing vision impairments, which two to three years later progress to complete blindness. This is the first indication of a progressive destruction of brai…
National Innovative Vision Research Award To Be Presented To IUPUI Faculty Member
Jason S. Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis, will be honored by the largest eye and vision research organization in the world for work which one day may lead to rev…
USC Researchers Develop Gene Therapy With Potential To Restore Sight To The Blind
Researchers at the Keck School of Medicine of the University of Southern California (USC) have developed a potential therapy for blindness that involves delivering a gene encoding a light-sensitive protein to inner retinal cells, enabling photosensitiv…
New Study Finds Eye Exams First To Detect Chronic Diseases
A new study released shows that eye exams are often the first to detect chronic diseases like diabetes and hypertension…
Video Interview: TearLab – Managing Dry Eye Patients Objectively
Featured Article
Webinar – Epimacular Brachytherapy for Neovascular AMD: The MERITAGE Study
Featured Article
Ophthalmologists Report Significant Changes In Prescribing Among Primary Open Angle Glaucoma Patients As Pfizer’s Xalatan Goes Generic
The impact of the genericization of Pfizer’s Xalatan at the end of March 2011 is reflected in changes to both current and anticipated ophthalmologist prescribing behavior for primary open angle glaucoma (POAG) patients.
Boy’s Wrong Wandering Eye Operated On, Then Other Eye Without Consulting Parents
4-year old Jesse Matlock went in to have surgery on his wandering right eye, but doctors operated on his left eye, then realized their mistake and immediately operated on the right eye without consulting with his parents, according to a KATU-TV report….
EyeMed Vision Care Expands Member Wellness Focus with Diabetic Eye Care Benefit
MASON, Ohio–(BUSINESS WIRE)–EyeMed Vision Care introduces a new Diabetic Eye Care benefit that provides follow-up care and supplementary diagnostic testing for patients with diabetes, a leading cause of adult blindness.
AMD Alliance Issues Global Call To Action To Improve Care Of Patients With Wet Age-Related Macular Degeneration (AMD)
The AMD Alliance International (AMDAI) today issued a global call to action to the vision care community, to ensure appropriate access to care for patients living with wet age-related macular degeneration (AMD), a condition where new blood vessels grow…
Why Defensive Medicine Won’t Go Away…and Might Become Worse
Defensive medicine is a fact of life, and some of the proposals involved with healthcare reform may keep it alive and well, says this physician. Medscape Business of Medicine
New Study Finds Eye Exams First To Detect Chronic Diseases
A new study released today shows that eye exams are often the first to detect chronic diseases like diabetes and hypertension. The study, conducted by Human Capital Management Services Group (HCMS), a national human capital consulting firm, found that …
Operation Eyesight Calls For Canada To Be A Leader In Eye Health Care
Operation Eyesight Universal, a Canada-based international non-governmental organization dedicated to eliminating avoidable blindness, supports Vision2020 Canada’s call for a national vision health strategy…
FDA Grants Priority Review For VEGF Trap-Eye For The Treatment Of Wet Age-Related Macular Degeneration
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s Biologics License Application (BLA) for VEGF Trap-Eye for the treatment of the neovascular form of age-relat…
MERLIN® Condensing Lens Assembly Facilitates Switches Between Corneal And Retinal Views
Volk Optical has built on its recently launched manually operated MERLIN® with a new Condensing Lens Assembly (CLA). This new option provides vitreoretinal surgeons the same detailed retinal views through the microscope, with the convenience of fully …